Anti-CCL18 / PARC Antibody (C-Terminus) IHC-plus™

• Supplier: LifeSpan Bioscience
• Catalog: LS-B929
• Prices: $450.00
• Sizes: 50 µg
• Host: Rabbit
• Clonality: Polyclonal
• Applications: IHC-P WB
• Species Reactivities: Human, Monkey
• Antigen: CCL18 / PARC antibody was raised against synthetic peptide from C-Terminus of human CCL18 (P55774, NP_002979). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey (100%); Rat (92%); Galago, Mouse, Panda (90%); Dog (84%).
• Purity/Format: Immunoaffinity purified
• Blocking Peptide: CCL18 / PARC Antibody Blocking Peptide
• Description: Rabbit Polyclonal
• Gene: CCL18
• Conjugate: Unconjugated. Also available conjugated with Biotin , FITC , HRP .

Product images

Anti-CCL18 antibody IHC of human spleen. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B929 concentration 10 ug/ml.

CCL18 antibody LS-B929 Western blot of Fetal Thymus lysate. Antibody concentration 1 ug/ml.

Fetal Thymus Lysate

Product References

M2 polarized macrophages and giant cells contribute to myofibrosis in - M2 polarized macrophages and giant cells contribute to myofibrosis in

Prokop S, Heppner FL, Goebel HH, Stenzel W. Am J Pathol. 2011 Mar;178(3):1279-86.